Adaptive Biotechnologies Corpor

Historical 13F Holders

Symbol
ADPT
CUSIP
00650F109
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 00650F109 since 12/18/2024, largest first.

Filer % of Class Filed
Viking Global Investors LP 13G/A
18.8% 5/15/2026
Event 3/31/2026
BlackRock, Inc. 13G/A 7.9% 1/21/2026
Event 12/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (6)
Nikko Asset Management Americas, Inc. 13G/A 4.6% 2/13/2025
Event 12/31/2024
Sumitomo Mitsui Trust Group, Inc. 13G/A
4.6% 2/4/2025
Event 12/31/2024
Integrated Core Strategies (US) LLC 13G/A
4.3% 1/27/2025
Event 12/31/2024
Rubric Capital Management LP 13G/A
4.1% 7/9/2025
Event 6/30/2025
ARK Investment Management LLC 13G/A
2.9% 6/6/2025
Event 5/31/2025
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 30 1.23 M $35.3 M
2026 Q2 310 159 M $3.48 B
2026 Q1 304 152 M $2.11 B
2025 Q4 293 150 M $2.44 B
2025 Q3 277 146 M $2.18 B
2025 Q2 250 149 M $1.74 B
2025 Q1 232 155 M $1.15 B
2024 Q4 213 143 M $859 M
2024 Q3 194 144 M $737 M
2024 Q2 184 150 M $544 M
2024 Q1 198 144 M $462 M
2023 Q4 210 146 M $714 M
2023 Q3 199 141 M $770 M
2023 Q2 219 137 M $921 M
2023 Q1 237 134 M $1.18 B
2022 Q4 236 135 M $1.03 B
2022 Q3 237 131 M $932 M
2022 Q2 221 134 M $1.08 B
2022 Q1 233 126 M $1.74 B
2021 Q4 226 124 M $3.48 B
2021 Q3 229 118 M $4.01 B
2021 Q2 244 118 M $4.81 B
2021 Q1 264 114 M $4.60 B
2020 Q4 270 114 M $6.77 B
2020 Q3 220 111 M $5.41 B
2020 Q2 213 101 M $4.89 B
2020 Q1 156 97.1 M $2.70 B
2019 Q4 141 86.5 M $2.59 B
2019 Q3 126 82.0 M $2.52 B
2019 Q2 113 78.2 M $3.74 B
2019 Q1 1 104 k $4.25 M
2016 Q3 2 248 $10.7 k
2016 Q2 1 13.0 $672.00
2016 Q1 1 9.00 $500.00